New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.
The Science of MDHAQ/RAPID3 Scores
Do patient self-reports provide valid data for evidence-based care in rheumatology practice?
Pain in Rheumatoid Arthritis
Out from the shadow of inflammation
Meet the Challenge of Primary CNS Vasculitis
Diagnosis and treatment of this rare and poorly understood condition
A&R Abstracts: CNS Vasculitis
For Further Reading
How Energy Shifts Lead to Systemic Illness
The impact of adaptive energy programs on the manifestations of chronic inflammatory disease
A Duet of Bone and the Immune System
Examining emerging perspectives in osteoimmunology
It Takes All Kinds
A look at the rheumatology practice team
Pain Perspective in Scleroderma
Systemic sclerosis (SSc; scleroderma) is a disease in which inflammatory and fibrotic changes result in overproduction and accumulation of collagen and other extracellular matrix proteins, resulting in intimal vascular damage, fibrosis, and occasionally organ dysfunction affecting the gastrointestinal, lung, heart, and renal systems. There are two classifications of SSc—limited cutaneous or CREST (calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, and telangectasias) syndrome, where skin thickening occurs mainly in the distal extremities and facial/neck areas and internal organ involvement, if present, occurs later in the disease process; and diffuse cutaneous disease where there is a more rapid progression of skin thickening from distal to proximal and organ involvement can be severe and occur early in the disease. As noted by various authors, there is no “crystal ball” into which one can look to see the outcome of the disease, and involvement varies significantly from one person to the next.
Revising Fibromyalgia: One Year Later
The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 9
- Next Page »